{"id":2672,"date":"2024-08-27T20:34:00","date_gmt":"2024-08-27T12:34:00","guid":{"rendered":"https:\/\/htbios.n.webweb.today\/news\/new-health-beverage-contract-manufacturer-enters-the-market-hantech-bio-tech-to-list-on-tpex-in-late-september\/"},"modified":"2026-08-27T10:11:47","modified_gmt":"2026-08-27T02:11:47","slug":"new-health-beverage-contract-manufacturer-enters-the-market-hantech-bio-tech-to-list-on-tpex-in-late-september","status":"publish","type":"news","link":"https:\/\/www.htbios.com\/en\/news\/new-health-beverage-contract-manufacturer-enters-the-market-hantech-bio-tech-to-list-on-tpex-in-late-september\/","title":{"rendered":"New Health Beverage Contract Manufacturer Enters the Market: HANTECH BIO-TECH to List on TPEx in Late September"},"content":{"rendered":"

HANTECH BIO-TECH (1294), a major contract manufacturer specializing in filling services for retort-pouch health beverages, is expected to officially list on the Taipei Exchange (TPEx) in late September. In 2023, HANTECH\u2019s annual revenue increased 106.65% year over year to NT$625 million, while net profit after tax reached NT$148 million, and basic earnings per share (EPS) stood at NT$7.66. The company has maintained strong growth over the past three years.<\/p>\n

HANTECH BIO-TECH reported revenue of NT$77 million in July 2024, representing year-over-year growth of 37.23%. Revenue for the first seven months of 2024 reached NT$474 million, up 56.20% from the same period last year.<\/p>\n

Founded in 2007, HANTECH BIO-TECH initially focused on the sale of traditional Chinese medicinal ingredients, particularly Guilu-related materials. In 2010, the company began developing low-temperature grinding technology for ultra-fine nano pearl powder. In 2012, it introduced horizontal filling machines and sterilization equipment for retort pouches and expanded into health supplement filling and contract manufacturing services.<\/p>\n

Today, HANTECH\u2019s core businesses include the R&D, ODM, and OEM manufacturing of liquid and crystal-jelly health supplements. The company provides comprehensive one-stop contract manufacturing services covering everything from formulation design to retort pouch filling and packaging, while also developing health supplement ingredients.<\/p>\n

HANTECH uses horizontal filling machines for its liquid filling processes and operates multiple units to ensure sufficient production capacity. The company also offers a variety of patented pouch molds for customers to choose from, helping establish its position as a major contract manufacturer of retort-pouch beverages in Taiwan.<\/p>\n

In addition, HANTECH\u2019s proprietary ultra-fine nano pearl powder manufacturing process and food-grade Guilu concentrated powder have been commercially available for many years. These products have become major supply sources in Taiwan, supported by a stable long-term customer base. The company also extensively incorporates these proprietary ingredients into its ODM products, contributing positively to profitability.<\/p>\n

In the post-pandemic era, growing consumer awareness of health and wellness has continued to drive expansion in Taiwan\u2019s health supplement market. HANTECH\u2019s liquid retort pouches offer several advantages, including a wide variety of pouch designs, high production yields with low leakage rates, refined manufacturing quality, compact packaging, and convenient transportation.<\/p>\n

These advantages have been well received by consumers, prompting more brand customers to transition their product packaging to the retort pouches primarily manufactured by HANTECH. As a result, this packaging format is gradually becoming an industry trend.<\/p>\n

In response to strong customer demand, HANTECH has expanded beyond its existing Yuanlin plant with the official launch of its Xihu Headquarters facility this year, providing additional production capacity.<\/p>\n

The company\u2019s sales were previously concentrated mainly in Taiwan, but it has recently accelerated its development of overseas markets and has already expanded its customer base to Hong Kong, Malaysia, Singapore, and mainland China.<\/p>\n

As well-known domestic and international health supplement brands increasingly launch functional liquid beverages and expand these products into overseas markets, HANTECH expects new customers, new products, and new sales regions to continue contributing to its growth momentum.<\/p>\n

HANTECH BIO-TECH reported revenue of NT$303 million in 2022, NT$625 million in 2023, and NT$397 million in the first half of 2024. Gross profit for the respective periods was NT$127 million, NT$281 million, and NT$162 million, while pre-tax profit reached NT$58 million, NT$185 million, and NT$104 million.<\/p>\n

Basic earnings per share for the same periods were NT$2.66, NT$7.66, and NT$3.24, respectively, reflecting strong growth in both revenue and profitability.<\/p>\n

With the long-term outlook for functional liquid beverages remaining positive, HANTECH aims to leverage its TPEx listing to strengthen access to capital, attract talent, enhance brand visibility, and secure more ODM orders. The company\u2019s future operating performance and continued business growth are therefore expected to attract attention from the investment community.<\/p>\n

Source:<\/p>\n

News Source: https:\/\/finance.ettoday.net\/news\/2805627<\/a><\/p>\n

\"\u6f22\u7530\u751f\u6280\u8463\u4e8b\u9577\u674e\u96e8\u9716\u3002\uff08\u5716\uff0f\u8a18\u8005\u9ad8\u5146\u9e9f\u651d\uff09\"
\u6f22\u7530\u751f\u6280\u8463\u4e8b\u9577\u674e\u96e8\u9716\u3002\uff08\u5716\uff0f\u8a18\u8005\u9ad8\u5146\u9e9f\u651d\uff09<\/figcaption><\/figure>\n","protected":false},"excerpt":{"rendered":"

HANTECH BIO-TECH (1294), a major contract manufacturer specializing in filling services for retort-pouch health beverages, is expected to officially list on the Taipei Exchange (TPEx) in late September. In 2023, HANTECH\u2019s annual revenue increased 106.65% year over year to NT$625 million, while net profit after tax reached NT$148 million, and basic earnings per share (EPS) […]<\/p>\n","protected":false},"featured_media":2084,"parent":0,"menu_order":49,"template":"","news_category":[165],"class_list":["post-2672","news","type-news","status-publish","has-post-thumbnail","hentry","news_category-media-coverage"],"acf":{"news_is_featured":false,"news_featured_start":null,"news_featured_end":null,"news_content_image":null},"_links":{"self":[{"href":"https:\/\/www.htbios.com\/en\/wp-json\/wp\/v2\/news\/2672","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.htbios.com\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.htbios.com\/en\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.htbios.com\/en\/wp-json\/wp\/v2\/media\/2084"}],"wp:attachment":[{"href":"https:\/\/www.htbios.com\/en\/wp-json\/wp\/v2\/media?parent=2672"}],"wp:term":[{"taxonomy":"news_category","embeddable":true,"href":"https:\/\/www.htbios.com\/en\/wp-json\/wp\/v2\/news_category?post=2672"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}